InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Monte Rosa Therapeutics, Inc.

GLUE Clue Score47
United States Fiscal year ends December CIK 0001826457 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Matthew Bowen
5 Oct 2026
Principal Accounting Officer
Sell
13
$10.56
$137.28
Markus Warmuth
16 Jul 2026
President & CEO
Sell
9,500
$23.18
$220.22K
Markus Warmuth
14 Apr 2026
President & CEO
Sell
8,000
$17.64
$141.12K
Philip Nickson
9 Apr 2026
Chief Business & Legal Officer
Sell
5,845
$17.69
$103.41K
Edmund Dunn
4 Mar 2026
Principal Accounting Officer
Sell
139
$17.96
$2.50K
Filip Janku
23 Feb 2026
Chief Medical Officer
Sell
9,189
$19.50
$179.16K
Sharon Townson
5 Jan 2026
Chief Scientific Officer
Sell
3,155
$15.17
$47.86K
Filip Janku
5 Jan 2026
Chief Medical Officer
Sell
3,155
$15.17
$47.86K
Markus Warmuth
5 Jan 2026
President & CEO
Sell
10,135
$15.17
$153.75K
Edmund Dunn
5 Jan 2026
Principal Accounting Officer
Sell
1,039
$15.17
$15.76K
Jennifer Champoux
5 Jan 2026
Chief Operating Officer
Sell
2,629
$15.17
$39.88K
Philip Nickson
5 Jan 2026
Chief Business & Legal Officer
Sell
3,155
$15.17
$47.86K
Show all 37 transactions →

What was left out

Form 4 filings counted 40
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 18
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 1,377,460
History held since 25 Jun 2021